Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
Despite the fact that great efforts have been made in the prevention and therapy of HIV-1 infection, HIV-1/AIDS remains a major threat to global human health. Highly active antiretroviral therapy (HAART) can suppress virus replication, but it cannot eradicate latent viral reservoirs in HIV-1/AIDS pa...
Main Authors: | Qiaoqiao Xiao, Deyin Guo, Shuliang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcimb.2019.00069/full |
Similar Items
Similar Items
-
Viral diversity is an obligate consideration in CRISPR/Cas9 designs for targeting the HIV reservoir
by: Pavitra Roychoudhury, et al.
Published: (2018-07-01) -
Various Aspects of a Gene Editing System—CRISPR–Cas9
by: Edyta Janik, et al.
Published: (2020-12-01) -
CRISPR/Cas9: Transcending the Reality of Genome Editing
by: Sergiu Chira, et al.
Published: (2017-06-01) -
Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4+ T cells from HIV-1 infection
by: Zhepeng Liu, et al.
Published: (2017-09-01) -
Optimizing CRISPR Cas9 Genome Editing System: A Review
by: Meen Bahadur Budhthoki, et al.
Published: (2017-03-01)